<h1>Advertising review of topical balm and roll-on claims: therapeutic, comparative, youth marketing, substantiation issues under Section 5</h1> A healthcare company launched an advertising campaign promoting topical balm and roll-on products as fast, natural pain relief and a safer alternative to oral tablets, targeting broad consumer groups including youth. The release touts product efficacy, rapid onset, household penetration metrics and legacy brand trust while positioning roll-ons as reducing tablet side-effects. Legally, these claims implicate advertising and consumer protection rules governing therapeutic and comparative claims, substantiation of efficacy and safety, marketing to younger audiences, and accuracy of penetration statistics; regulatory review, potential disclosure requirements, and scrutiny of health claims and endorsements are foreseeable.